APA

Mejía M., Herrera-Bringas D., Pérez-Román D. I., Rivero H., Mateos-Toledo H., Castorena-García P., Figueroa J. E. & Rojas-Serrano J. (20180108). Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF). : Respiratory medicine.

Chicago

Mejía Mayra, Herrera-Bringas Denisse, Pérez-Román Diana I, Rivero Hermes, Mateos-Toledo Heidegger, Castorena-García Pedro, Figueroa José E and Rojas-Serrano Jorge. 20180108. Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF). : Respiratory medicine.

Harvard

Mejía M., Herrera-Bringas D., Pérez-Román D. I., Rivero H., Mateos-Toledo H., Castorena-García P., Figueroa J. E. and Rojas-Serrano J. (20180108). Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF). : Respiratory medicine.

MLA

Mejía Mayra, Herrera-Bringas Denisse, Pérez-Román Diana I, Rivero Hermes, Mateos-Toledo Heidegger, Castorena-García Pedro, Figueroa José E and Rojas-Serrano Jorge. Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF). : Respiratory medicine. 20180108.